Invention Grant
- Patent Title: Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
-
Application No.: US16883139Application Date: 2020-05-26
-
Publication No.: US11690918B2Publication Date: 2023-07-04
- Inventor: Patricius Hendrikus Cornelis Van Berkel , Philip Wilson Howard
- Applicant: ADC THERAPEUTICS S.A. , MEDIMMUNE LIMITED
- Applicant Address: CH Epalinges
- Assignee: MEDIMMUNE LIMITED,ADC THERAPEUTICS S.A.
- Current Assignee: MEDIMMUNE LIMITED,ADC THERAPEUTICS S.A.
- Current Assignee Address: GB Cambridge; CH Epalinges
- Agency: Casimir Jones SC
- Agent Lisa Mueller
- The original application number of the division: US14434826
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K47/68 ; A61K31/551 ; C07K16/10 ; C07K16/28 ; A61K31/5517 ; A61K45/06
Abstract:
The disclosure provides conjugates of an isolated humanized anti-CD22 antibody and PBD dimers.
Public/Granted literature
- US20200306385A1 PYRROLOBENZODIAZEPINE-ANTI-CD22 ANTIBODY CONJUGATES Public/Granted day:2020-10-01
Information query
